Kind Therapeutics, a client of MariMed Inc., has successfully passed the Maryland Cannabis Commission compliance inspection of its renovated facility. MariMed purchased the 180,000 sq. ft. property, which had been vacant for a decade, and renovated it into a secure cannabis cultivation and production facility.

Kind Therapeutics is now leasing the space, which is expected to employ up to 100 people. It now has the capacity to produce over two tons of high quality organic cannabis medicine, and the cultivation process has successful begun.

“MariMed has been a true partner in providing expertise and best practices to navigate the complex regulatory requirements,” said Kind Therapeutics chief executive officer Dr. Susan Zimmerman. “They took us smoothly from license applicant to completion of a state of the art facility that will create some of the highest quality products in the state.”